Á¤»ó¾È¾Ð³ì³»Àå¿¡¼ ºê¸°Á¹¶ó¹Ìµå 1%¿Í Ƽ¸ô·Ñ 0.5% È¥ÇÕÁ¦Á¦ÀÇ È¿°ú
The Effect of Fixed Combination of Brinzolamide 1% and Timolol 0.5% in Normal-Tension Glaucoma
´ëÇѾȰúÇÐȸÁö 2014³â 55±Ç 7È£ p.1056 ~ p.1063
¹ÚÇѼ®(Park Han-Seok) - ¼º±Õ°ü´ëÇб³ ÀÇ°ú´ëÇÐ °ºÏ»ï¼ºº´¿ø ¾È°úÇб³½Ç
ÃÖö¿µ(Choi Chul-Young) - ¼º±Õ°ü´ëÇб³ ÀÇ°ú´ëÇÐ °ºÏ»ï¼ºº´¿ø ¾È°úÇб³½Ç
¹èÁ¤ÈÆ(Bae Jeong-Hun) - ¼º±Õ°ü´ëÇб³ ÀÇ°ú´ëÇÐ °ºÏ»ï¼ºº´¿ø ¾È°úÇб³½Ç
±èÁظð(Kim Joon-Mo) - ¼º±Õ°ü´ëÇб³ ÀÇ°ú´ëÇÐ °ºÏ»ï¼ºº´¿ø ¾È°úÇб³½Ç
Abstract
Purpose: We conducted a study to evaluate the effects of brinzolamide/timolol fixed combination (BTFC) in normal-tension glaucoma (NTG) patients.
Methods: We reviewed the records of 33 normal-tension glaucoma patients treated with BTFC in the unilateral eye. We measured intraocular pressure (IOP) every 2 and 1/2 hours between 09:00 am and 04:30 pm. After using BTFC at 8:00 am and 8:00 pm for 6 months, we measured the IOP at the same time period. We analyzed and compared the IOP of eyes treated with BTFC and contralateral eyes.
Results: The mean reduction in IOP was -2.85 ¡¾ 1.43 mm Hg (-18.36 ¡¾ 8.58%) in the eyes treated with BTFC and -2.21 ¡¾ 1.73 mm Hg (-13.90 ¡¾ 10.66%) in the contralateral eyes. The IOP lowering effect was greater in the eyes treated with BTFC than in the contralateral eyes. After 6 months of BTFC instillation, the changes in IOP measurements were the lowest at 11:30 am and increased at each time point afterwards. The greatest reduction in IOP was observed at 1 month; however, significant IOP reduction was observed at 3 and 6 months in both BTFC and contralateral eyes. There was no serious adverse event causing ocular damage.
Conclusions: BTFC provided a significant IOP reduction in both BTFC and contralateral eyes in NTG patients.
Å°¿öµå
Brinzolamide, Fixed combination, Intraocular pressure, Normal-tension glaucoma, Timolol
KMID :
0360220140550071056
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
À¯È¿¼º°á°ú(Recomendation)